Kripa Shankar
Also known as: Kripa
The University of Texas Southwestern Medical Center
Research areas: Medicine · Endocrinology, Diabetes and Metabolism · Regulation of Appetite and Obesity · Adipokines, Inflammation, and Metabolic Diseases · Adipose Tissue and Metabolism
About
Kripa Shankar, Ph.D. is an Instructor in the Center for Human Nutrition at UT Southwestern Medical Center and a member of its Center of Hypothalamic Research.
Originally from India, Dr. Shankar holds a bachelor’s degree in Biotechnology from Chhatrapati SahuJi Maharaj University in Kanpur, India, and a master’s degree in Biotechnology from Babasaheb Bhimrao Ambedkar University, in Lucknow, India. He earned his doctorate in Life Sciences from Jawaharlal Nehru University in Delhi, India. Dr. Shankar did his postdoctoral research in Dr. Jeffrey Zigman’s lab in the Center for Hypothalamic Research where he investigated the role of ghrelin in body weight and glucose homeostasis.
Dr. Shankar’s research interests include blood glucose counter-regulation, body weight, and energy homeostasis. His research work has resulted in 40+ peer-reviewed publications. In 2021, the Obesity Society awarded him with the Ethan Sims Young Investigator Award at the Obesity Week meeting.
Employment
- 2024 - Present
- 2021 - 2024
- 2017 - 2021
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (49)
- A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice Save
- Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in mice (vol 133, e169349, 2023) Save
- Impact of Ghrelin on Islet Size in Nonpregnant and Pregnant Female Mice Save
- Impact of Ghrelin on Islet Size in Nonpregnant and Pregnant Female Mice (vol 165, bqae048, 2024) Save
- Ghrelin-responsive mediobasal hypothalamic neurons mediate exercise-associated food intake and exercise endurance Save
- Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice Save
- A LEAP2 Analog Causes Marked Weight Loss and Reduces Hepatic Steatosis in Mice Save
- Combination Mirabegron plus Atenolol Therapy Limits Weight Gain in High-Fat Diet-Fed Mice Save
- Effects of Thermoneutrality in a Prader-Willi Syndrome Mouse Model Save
- Effects of thermoneutrality on food intake, body weight, and body composition in a Prader-Willi syndrome mouse model Save
- Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in mice Save
- Ghrelin-Responsive Mediobasal Hypothalamic Neurons Mediate Exercise-Induced Food Intake and Endurance Save
- Reducing Ghrelin Levels as a Novel Method to Increase Pancreatic Beta-Cell Mass Save
- Role of Growth Hormone in Ghrelin’s Metabolic Actions Save
- Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions Save
- Ghrelin cell-expressed insulin receptors mediate meal- and obesity-induced declines in plasma ghrelin Save
- High Coexpression of the Ghrelin and LEAP2 Receptor GHSR With Pancreatic Polypeptide in Mouse and Human Islets Save
- LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue Save
- Ghrelin Protects Against Insulin-Induced Hypoglycemia in a Mouse Model of Type 1 Diabetes Mellitus. Save
- ?A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes? Save